Jurgi Camblong
Gründer bei SOPHIA GENETICS SA
Vermögen: 12 Mio $ am 31.05.2024
Profil
Jurgi Camblong is the founder of SOPHiA GENETICS SA, which was founded in 2011.
He is currently the Chairman of Agora Care SA and the Director of Swiss Biotech Association.
Dr. Camblong was the Chief Executive Officer of Gene Predictis SA from 2010 to 2011.
He was also an Associate at the University of Oxford and the University of Geneva.
Dr. Camblong holds an MBA from École Polytechnique Fédérale de Lausanne and a doctorate from the University of Geneva.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SOPHIA GENETICS SA
3,76% | 15.02.2024 | 2 460 081 ( 3,76% ) | 12 Mio $ | 31.05.2024 |
Aktive Positionen von Jurgi Camblong
| Unternehmen | Position | Beginn |
|---|---|---|
| SOPHIA GENETICS SA | Gründer | 01.01.2011 |
Swiss Biotech Association
 Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | Direktor/Vorstandsmitglied | - |
Agora Care SA
 Agora Care SA Information Technology ServicesTechnology Services Agora Care SA provides IT services. The Swiss company was founded in 2021 by Joël Spaltenstein. Osman Ratib has been the CEO of the company since 2021. | Vorsitzender | - |
Ehemalige bekannte Positionen von Jurgi Camblong
| Unternehmen | Position | Ende |
|---|---|---|
GENE PREDICTIS SA
 GENE PREDICTIS SA Miscellaneous Commercial ServicesCommercial Services Part of NIMGenetics Genómica y Medicina SL, Gene Predictis SA engages in the development of diagnostic tools based on genetics that allow treatments for patients. The company is based in Lausanne, Switzerland. The Swiss company was founded in 2004. Goranka Tanackovic has been the CEO of the company since 2011. Gene Predictis was acquired by NIMGenetics Genómica y Medicina SL on February 13, 2023. | Vorstandsvorsitzender | 01.01.2011 |
| University of Geneva | Corporate Officer/Principal | - |
| University of Oxford | Corporate Officer/Principal | - |
Ausbildung von Jurgi Camblong
| University of Geneva | Doctorate Degree |
| École Polytechnique Fédérale de Lausanne | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SOPHIA GENETICS SA | Technology Services |
| Private Unternehmen | 3 |
|---|---|
GENE PREDICTIS SA
GENE PREDICTIS SA Miscellaneous Commercial ServicesCommercial Services Part of NIMGenetics Genómica y Medicina SL, Gene Predictis SA engages in the development of diagnostic tools based on genetics that allow treatments for patients. The company is based in Lausanne, Switzerland. The Swiss company was founded in 2004. Goranka Tanackovic has been the CEO of the company since 2011. Gene Predictis was acquired by NIMGenetics Genómica y Medicina SL on February 13, 2023. | Commercial Services |
Swiss Biotech Association
Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | Commercial Services |
Agora Care SA
Agora Care SA Information Technology ServicesTechnology Services Agora Care SA provides IT services. The Swiss company was founded in 2021 by Joël Spaltenstein. Osman Ratib has been the CEO of the company since 2021. | Technology Services |
